Clinical Trial Update: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing capecitabine with sorafenib or placebo in locally advanced or metastatic HER2-negative breast cancer has been completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-09-03